TrialHepatology (Baltimore, Md.)2018

Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial.

David Wyles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.